Proteomics

Dataset Information

0

Super-paramagnetic iron oxide nanoparticles reprogram the tumor microenvironment and reduce lung cancer growth


ABSTRACT: Tumor associated macrophages (TAMs) are known to play a role in a multitude of processes that facilitate lung cancer growth, including the suppression of tumoricidal immune activation and the absorption of chemotherapeutics. Therefore, deciphering new therapies to reprogram TAMs towards an anti-tumor phenotype is at the cutting-edge of therapy development. The presence of iron-loaded macrophages has been associated with a better prognosis in lung cancer patients. Iron accumulation in macrophages stimulates pro-tumoricidal macrophage activity that triggers cytotoxic T-cell responses in the tumor microenvironment. In this study, we propose super-paramagnetic iron oxide nanoparticles (SPIONs) as a promising anti-lung cancer adjuvant therapy to reduce tumor cell growth. We used SPIONs to target iron to macrophages and observed that SPION-loaded macrophages reduced tumor cell growth due to the oxidative stress. Additionally, we found that SPIONs completely rewire the tumor microenvironment in mice towards an anti-tumor state and that in combination with crizotinib, a lung cancer targeted therapy, SPIONs show an additive effect in decelerating tumor growth

INSTRUMENT(S): Orbitrap Exploris 480

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Cell Culture, Macrophage

DISEASE(S): Lung Carcinoma

SUBMITTER: Marcel Schilling  

LAB HEAD: Prof. Ursula Klingmüller

PROVIDER: PXD040145 | Pride | 2024-04-18

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
MaxQuant_Output.7z Other
OTEX_211129_21-022_04_old_1.raw Raw
OTEX_211129_21-022_06_old_2.raw Raw
OTEX_211129_21-022_08_old_3.raw Raw
OTEX_211129_21-022_10_old_4.raw Raw
Items per page:
1 - 5 of 68
altmetric image

Publications


ALK-positive NSCLC patients demonstrate initial responses to ALK tyrosine kinase inhibitor (TKI) treatments, but eventually develop resistance, causing rapid tumor relapse and poor survival rates. Growing evidence suggests that the combination of drug and immune therapies greatly improves patient survival; however, due to the low immunogenicity of the tumors, ALK-positive patients do not respond to currently available immunotherapies. Tumor-associated macrophages (TAMs) play a crucial role in fa  ...[more]

Similar Datasets

2010-01-05 | E-GEOD-12863 | biostudies-arrayexpress
2021-02-16 | PXD022673 | Pride
2021-02-16 | PXD022674 | Pride
2024-04-11 | PXD042728 | Pride
2018-07-26 | GSE96944 | GEO
2012-04-01 | E-GEOD-34903 | biostudies-arrayexpress
2023-05-16 | GSE227560 | GEO
2021-09-25 | GSE162669 | GEO
2015-10-12 | PXD000766 | Pride
2012-03-31 | E-GEOD-18804 | biostudies-arrayexpress